A detailed history of Gsa Capital Partners LLP transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 153,070 shares of CDMO stock, worth $1.83 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
153,070
Previous 77,597 97.26%
Holding current value
$1.83 Million
Previous $554,000 214.44%
% of portfolio
0.13%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$6.7 - $12.45 $505,669 - $939,638
75,473 Added 97.26%
153,070 $1.74 Million
Q2 2024

Aug 15, 2024

SELL
$6.34 - $9.28 $95,721 - $140,109
-15,098 Reduced 16.29%
77,597 $554,000
Q1 2024

May 03, 2024

BUY
$5.86 - $8.79 $433,417 - $650,125
73,962 Added 394.82%
92,695 $621,000
Q4 2023

Feb 16, 2024

SELL
$4.64 - $9.56 $98,762 - $203,484
-21,285 Reduced 53.19%
18,733 $121,000
Q3 2023

Nov 15, 2023

BUY
$9.4 - $14.04 $253,659 - $378,869
26,985 Added 207.05%
40,018 $377,000
Q2 2023

Aug 14, 2023

BUY
$12.96 - $20.93 $168,907 - $272,780
13,033 New
13,033 $182,000
Q4 2022

Feb 13, 2023

BUY
$12.61 - $18.74 $303,131 - $450,490
24,039 Added 193.94%
36,434 $502,000
Q3 2022

Nov 14, 2022

SELL
$15.33 - $20.36 $938,640 - $1.25 Million
-61,229 Reduced 83.16%
12,395 $237,000
Q2 2022

Aug 09, 2022

BUY
$11.63 - $21.55 $856,247 - $1.59 Million
73,624 New
73,624 $1.12 Million
Q3 2021

Nov 12, 2021

SELL
$19.05 - $28.32 $372,808 - $554,222
-19,570 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$18.93 - $25.65 $370,460 - $501,970
19,570 New
19,570 $502,000
Q4 2020

Feb 03, 2021

SELL
$7.25 - $11.76 $307,334 - $498,518
-42,391 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$6.53 - $8.6 $89,996 - $118,525
13,782 Added 48.17%
42,391 $323,000
Q2 2020

Aug 11, 2020

SELL
$4.11 - $6.78 $313,079 - $516,466
-76,175 Reduced 72.7%
28,609 $188,000
Q1 2020

May 12, 2020

BUY
$3.15 - $7.39 $198,169 - $464,912
62,911 Added 150.24%
104,784 $535,000
Q4 2019

Feb 12, 2020

BUY
$5.01 - $8.16 $209,783 - $341,683
41,873 New
41,873 $321,000
Q3 2019

Nov 12, 2019

SELL
$5.07 - $7.08 $170,270 - $237,774
-33,584 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$3.43 - $5.6 $135,083 - $220,544
-39,383 Reduced 53.97%
33,584 $188,000
Q1 2019

May 15, 2019

BUY
$3.56 - $4.82 $259,762 - $351,700
72,967 New
72,967 $310,000
Q4 2018

Feb 12, 2019

SELL
$4.04 - $6.75 $95,748 - $159,975
-23,700 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$4.28 - $7.32 $101,436 - $173,484
23,700 New
23,700 $163,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $742M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.